Publications authored by CHSPR faculty and staff from 2009 to the present are listed here. Older peer-reviewed publications are usually available from individual journals and can be searched for using PubMed. Older reports published by CHSPR (from 1973) are available from the UBC Library cIRcle database. If you cannot find a specific publication, please contact us.
McClean AR, Cheng L, Bansback N, Clement F, Tadrous M, Harrison M, Law MR. Uptake and spending on biosimilar infliximab and etanercept after new start and switching policies in Canada: An interrupted time series analysis. Arthritis Care Res (Hoboken). 2023 Feb 8. doi: 10.1002/acr.25099. Online ahead of print. Read more
Laba TL, Worthington HC, Cheng L, Chan FKI, Bansback N, Law MR. The impact of the Choosing Wisely Canada campaign on the simultaneous use of angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers: interrupted time-series analysis. CMAJ Open. 2022 Dec 13;10(4):E1059-E1066. doi: 10.9778/cmajo.20210185. Print 2022 Oct-Dec. Read more
Tadrous M, Graili P, Hayes KN, Neville HL, Houlihan J, Clement F, Guertin JR, Law MR, Gomes T. Canadian Trends in Estimated Pharmaceutical Drug Purchases and Projections: 2023. Canadian Journal of Health Technologies. 2022 Nov; 2(11)Read more
Morrow RL, Mintzes B, Gray G, Law MR, Garrison S, Dormuth CR. Factors relating to nonpublication and publication bias in clinical trials in Canada: a qualitative interview study. Br J Clin Pharmacol. 2022 Oct 21. doi: 10.1111/bcp.15574. Online ahead of print. Read more
Miregwa BN, Holbrook A, Law MR, Lavis JN, Thabane L, Dolovich L, Wilson MG. The impact of OHIP+ pharmacare on use and costs of public drug plans among children and youth in Ontario: a time-series analysis. CMAJ Open. 2022 Sep 27;10(3):E848-E855. doi: 10.9778/cmajo.20210295. Read more
Luz TCB, de Castro AKS, Marques IC, Cota BB, Alves JC, Law MR. Performance of a pharmaceutical services regionalization strategy policy in Minas Gerais, Brazil: Pre-post analysis from ERAF project. Front Pharmacol. 2022 Sep 2;13:953990. doi: 10.3389/fphar.2022.953990. Read more
Wong ST, Morkem R, Leis J, Levinson W, Patey A, Durance A, Barber D. Potentially inappropriate antibiotic prescribing for respiratory tract infections in Canadian primary care: Results from the Canadian Primary Care Sentinel Surveillance Network. Kingston, ON: Canadian Primary Care Sentinel Surveillance Network; April 2022. Read more
McClean AR, Law MR, Harrison M, Bansback N, Gomes T, Tadrous M. Uptake of biosimilar drugs in Canada: analysis of provincial policies and usage data. CMAJ. 2022 Apr 19;194(15):E556-E560. doi: 10.1503/cmaj.211478. Read more
Wong S, Rajapakshe S, Barber D, Patey A, Levinson W, Morkem R, Hurwitz G, Wintermute K, Leis JA. Antibiotic prescribing for respiratory tract infection across a national primary care network in 2019. Can Commun Dis Rep. 2022 Apr 6;48(4):157-163. doi: 10.14745/ccdr.v48i04a06. eCollection 2022 Apr 6. Read more
Hofmeister M, Sivakumar A, Clement F, Hayes KN, Law M, Guertin JR, Neville HL, Tadrous M. Trends in Canadian prescription drug purchasing: 2001-2020. J Pharm Policy Pract. 2022 Mar 17;15(1):20. doi: 10.1186/s40545-022-00420-4. Read more
Alves JC, Law MR, Luz TCB. Prevalence and Factors Associated With Out-of-Pocket Pharmaceutical Expenditure Among Primary Healthcare Patients: Evidence From the Prover Project. Value Health Reg Issues. 2022 Mar 17;30:83-90. doi: 10.1016/j.vhri.2022.01.006. Online ahead of print. Read more
Garrison SR, Kolber MR, Allan GM, Bakal J, Green L, Singer A, Trueman DR, McAlister FA, Padwal RS, Hill MD, Manns B, McGrail K, O'Neill B, Greiver M, Froentjes LS, Manca DP, Mangin D, Wong ST, MacLean C, Kirkwood JE, McCracken R, McCormack JP, Norris C, Korownyk T. Bedtime versus morning use of antihypertensives for cardiovascular risk reduction (BedMed): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trial. BMJ Open. 2022 Feb 24;12(2):e059711. doi: 10.1136/bmjopen-2021-059711. Read more
Morrow RL, Mintzes B, Gray G, Law MR, Garrison S, Dormuth CR. Industry Sponsor Influence in Clinical Trial Reporting in Canada: A Qualitative Interview Study. Clin Ther. 2021 Dec 23:S0149-2918(21)00493-8. Online ahead of print. Read more
Schummers L, Darling EK, Dunn S, McGrail K, Gayowsky A, Law MR, Laba TL, Kaczorowski J, Norman WV. Abortion Safety and Use with Normally Prescribed Mifepristone in Canada. N Engl J Med. 2021 Dec 8. Online ahead of print. Read more
Zeitouny S, Suda KJ, Mitsantisuk K, Law MR, Tadrous M. Mapping global trends in vaccine sales before and during the first wave of the COVID-19 pandemic: a cross-sectional time-series analysis. BMJ Glob Health. 2021 Dec;6(12):e006874. Read more
Tadrous M, Shakeri A, Hayes KN, Neville HL, Houlihan J, Clement F, Guertin JR, Law MR, Gomes T. Canadian Trends and Projections in Prescription Drug Purchases: 2001–2023. Canadian Journal of Health Technologies. 2021;1(11). Read more
Persaud N, Bedard M, Boozary A, Glazier RH, Gomes T, Hwang SW, Juni P, Law MR, Mamdani M, Manns B, Martin D, Morgan SG, Oh P, Pinto AD, Shah BR, Sullivan F, Umali N, Thorpe KE, Tu K, Laupacis A; Carefully seLected and Easily Accessible at No Charge Medications (CLEAN Meds) study team. Adherence at 2 years with distribution of essential medicines at no charge: The CLEAN Meds randomized clinical trial. PLoS Med. 2021 May 21;18(5):e1003590. Read more
Chew C, Aguiar M, Bansback N, Law MR, Harrison M. Patient perspectives on the British Columbia Biosimilars Initiative: a qualitative descriptive study. Rheumatol Int. 2021 May 7:1-12. Read more
Ho H, Janjua NZ, McGrail KM, Harrison M; BC Hepatitis Testers Cohort Team, Law MR. The impact of public coverage of newer hepatitis C medications on utilization, adherence, and costs in British Columbia. PLoS One. 2021 Mar 1;16(3):e0247843. Read more
Holbrook AM, Wang M, Lee M, Chen Z, Garcia M, Nguyen L, Ford A, Manji S, Law MR. Cost-related medication nonadherence in Canada: a systematic review of prevalence, predictors, and clinical impact. Syst Rev. 2021 Jan 6;10(1):11. Read more